Jianling Zou
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
2.5D Deep Learning and Machine Learning for Discriminative DLBCL and IDC with Radiomics on PET/CT.
Journal: Bioengineering (Basel, Switzerland)
Published: July 02, 2025
Survival of hepatectomy in colorectal cancer patients with ten or more liver metastases: a retrospective cohort study of multidisciplinary treatment.
Journal: Journal of gastrointestinal oncology
Published: March 21, 2025
Transcriptome Landscape of Cancer-Associated Fibroblasts in Human PDAC.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 18, 2024
Combination of LowDose Epigenetic Modifiers and TIC10 for the Activation of Antitumor Immunity and Inhibition of Tumor Growth in Gastrointestinal Cancer.
Journal: Cancer medicine
Published: September 15, 2024
Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers.
Journal: Cancer immunology, immunotherapy : CII
Published: March 15, 2024
PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective Study.
Journal: JCO precision oncology
Published: March 30, 2023
Longitudinal plasma proteome profiling reveals the diversity of biomarkers for diagnosis and cetuximab therapy response of colorectal cancer.
Journal: Nature communications
Published: February 27, 2023
Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancers.
Journal: Frontiers in immunology
Published: July 06, 2022
Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy.
Journal: Frontiers in oncology
Published: December 07, 2021
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer.
Journal: Cancer biology & medicine
Published: September 27, 2021
Germline HLA-B evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer.
Journal: Genome medicine
Published: March 08, 2021
Last Updated: 09/26/2026